The right clinical trial tech stack isn’t the most complete one; it’s the one built with sites, funded fairly, and designed to remove friction, not add it.
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
AI‑Readiness Checklist: Is Your Clinical Data Environment Ready?
AI impact depends on solid data practices, good governance, and team alignment. This piece highlights what to assess and how organizations can build readiness for future initiatives.
-
Your CRAs Aren't Monitoring. They're Managing Workarounds.
CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.
-
7 eCOA Design Recommendations: Insights From Sites And CRAs
Signant joined a group of C-Path members including other eCOA solution providers, sponsors, and regulators for a GBTI project that revealed several opportunities to improve eCOA usability and flexibility.
-
Gradually Investing In Direct Data Capture Is Inevitable
Given study decentralization and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”
-
ICH E6(R3) Is Here: What Your Centralized Monitoring Strategy Needs
ICH E6(R3) turns best practices into regulatory mandates. Learn how to maintain sponsor accountability and implement proportionate centralized monitoring through a unified, auditable data layer.
-
From Months To Hours: MMC Medical's EDC Revolution
Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.
-
The Real Reason Sites Haven't Digitized
Reducing site burden doesn’t always require major change. Streamlining a single workflow can improve efficiency, strengthen compliance, and give site staff more time to focus on patients and trial execution.
-
Reframing Vendor Selection: Beyond Price And Past Relationships
An RFP is more than a budget tool — it’s a strategic communication document that guides vendors, clarifies expectations, and enables informed, data-driven sponsor decisions.
-
How To Budget For Site Payments Success
Unearth how bringing the functions of medical writing, clinical data management, and electronic data capture can positively impact the creation of a budget and payment process.
-
Early-Stage Biotech's AI Advantage Is A Window That Closes
FDA AI guidance won’t build your strategy for you. Learn how biotech teams can avoid retrofits and design smarter clinical AI from day one.
RECENT NEWSLETTERS
- 06.11.26 -- AI Governance, Site Tech Risk, And Trial Efficiency Gains
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials